INCR insider trading
NasdaqGM HealthcareIntercure Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Intercure Ltd.
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
Company website: www.intercure.co
INCR insider activity at a glance
FilingIQ has scored 230 insider transactions for INCR since Nov 13, 2014. The most recent filing in our index is dated Jun 9, 2026.
Across the full history, 1 open-market purchases
and 78 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on INCR insider trades is 62.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for INCR?
- FilingIQ tracks 230 Form 4 insider transactions for INCR (Intercure Ltd.), covering filings from Nov 13, 2014 onwards. 1 of those were filed in the last 90 days.
- Are INCR insiders net buyers or net sellers?
- Across the full Form 4 history for INCR, 1 transactions (0%) were open-market purchases and 78 (34%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does INCR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is INCR in?
- Intercure Ltd. (INCR) is classified in the Healthcare sector, specifically Drug Manufacturers - Specialty & Generic, with a current market capitalisation of $64.91M.
Methodology & sources
Every INCR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.